Viewing Study NCT00243568


Ignite Creation Date: 2025-12-24 @ 5:41 PM
Ignite Modification Date: 2025-12-25 @ 3:10 PM
Study NCT ID: NCT00243568
Status: WITHDRAWN
Last Update Posted: 2019-09-12
First Post: 2005-10-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR-E2) (Study P04285
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module